Can Your Generic Drug Skip BE Studies? Biowaivers Decoded

#Bioequivalence #Biowaiver #Pharmacy Can every generic medicine skip a Bioequivalence (BE) Study? Learn the complete concept of Biowaivers, BCS Classification, Dissolution Studies and Regulatory Requirements in this comprehensive Bioequivalence Masterclass Episode 4. Welcome to Episode 4 of the Complete Bioequivalence (BE) Studies Masterclass by PharmaHealth Insights. In this episode, Rajesh Kapoor explains one of the most important concepts in Generic Drug Development—Biowaivers. You'll learn: ✅ What is a Biowaiver? ✅ Why Bioequivalence Studies can sometimes be waived ✅ Complete Biopharmaceutics Classification System (BCS) ✅ BCS Class I, II, III & IV explained ✅ High Solubility vs High Permeability ✅ Dissolution Studies Explained ✅ Comparative Dissolution Profile ✅ f2 Similarity Factor ✅ Immediate Release Tablets ✅ Generic Drug Development ✅ Regulatory Perspective ✅ Interview Questions ✅ Industry Practical Examples This video is designed for: • B.Pharm Students • M.Pharm Students • Pharm.D Students • Regulatory Affairs Professionals • Formulation & Development Scientists • Analytical Development Scientists • Clinical Research Professionals • Quality Assurance Professionals • Generic Pharmaceutical Industry • BE Study Professionals 📚 Bioequivalence Masterclass Playlist Watch the complete course from Episode 1 to build your knowledge step by step. Subscribe to PharmaHealth Insights for high-quality Pharmaceutical Education, Regulatory Affairs, GMP, Bioequivalence Studies, Formulation Development and Career Guidance. Chapters: 00:00 Introduction 01:10 What is a Biowaiver? 02:20 Why are Biowaivers Allowed? 04:50 BCS Classification Explained 05:03 BCS Class I 06:25 BCS Class II 08:00 BCS Class III 09:30 BCS Class IV 14:00 Dissolution Studies 16:00 f2 Similarity Factor 17:30 Comparative Dissolution 18:42 Practical Example 24:50 Industry Applications 26:20 Interview Tips 27:15 Episode Summary 28:55 Next Episode Preview Get all Pharma and Healthcare content and tips at: Linkedin:   / pharmahealth-insights   Facebook:  / rajesh19733   Twitter: https://x.com/rajesh19733 Blog: https://rajeshkapoorpharma.blogspot.com WhatsApp: https://whatsapp.com/channel/0029Vavm... Mini website: https://deltacard.me/pharmahealthinsi... Website: @armahealthinsights/home Bioequivalence BE Studies Biowaiver Generic Drug Development Pharmaceutical Industry BCS Classification Regulatory Affairs Pharmacy Education CDSCO USFDA WHO GMP Clinical Research Dissolution Study Formulation Development PharmaHealth Insights Rajesh Kapoor